- Home
- NVO vs MRVL Comparison
NVO vs MRVL Comparison
Compare NVO & MRVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | MRVL |
|---|---|---|
| Founded | 1923 | 1995 |
| Country | Denmark | United States |
| Employees | 69500 | 7480 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4B | 242.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NVO | MRVL |
|---|---|---|
| Price | $47.59 | $263.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 32 |
| Target Price | $51.00 | ★ $120.28 |
| AVG Volume (30 Days) | 11.9M | ★ 59.5M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | ★ 3.19% | 0.15% |
| EPS Growth | N/A | ★ 400.98 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $8,194,600,000.00 |
| Revenue This Year | N/A | $35.14 |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | ★ $13.60 | $7,021.25 |
| Revenue Growth | N/A | ★ 42.09 |
| 52 Week Low | $35.12 | $61.44 |
| 52 Week High | $71.80 | $329.88 |
Technical Indicators
Market Signals| Indicator | NVO | MRVL |
|---|---|---|
| Relative Strength Index (RSI) | 65.49 | 51.71 |
| Support Level | $47.52 | $244.00 |
| Resistance Level | $47.79 | $327.04 |
| Average True Range (ATR) | 1.32 | 24.89 |
| MACD | 0.47 | -6.14 |
| Stochastic Oscillator | 87.73 | 22.63 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About MRVL Marvell Technology Inc.
Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.